Jianjun Liu

1.5k citations
32 papers · 1.1k indexed · h-index 19
Topics
Cancer, Hypoxia, and Metabolism (6 papers)RNA modifications and cancer (6 papers)Cancer, Lipids, and Metabolism (5 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Jianjun Liu

31 papers receiving 1.1k citations

Peers

Jianjun Liu
Comparison fields: 5 of 89
  • Molecular Biology 746
  • Cancer Research 508
  • Oncology 154
  • Radiology, Nuclear Medicine and Imaging 97
  • Pulmonary and Respiratory Medicine 93
Replace Yun-Xin Lu with:
Yun-Xin Lu China
Hyun Min Jeon South Korea
Qingguo Li China
Jangsoon Lee United States
Gabriela Andrejeva United States
Viney Jain India
Qingquan Li China
Antoinette van Weverwijk United Kingdom
David Cerna United States
Jiaqiang Dong China
Jianjun Liu relative to Yun-Xin Lu China Yun-Xin Lu's profile →
Citations per field
00.5×1.5×2.3×
Yun-Xin Lu · 1×
Citations per year

Countries citing papers authored by Jianjun Liu

Since Specialization
Citations

This map shows the geographic impact of Jianjun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianjun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianjun Liu more than expected).

Fields of papers citing papers by Jianjun Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianjun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianjun Liu. The network helps show where Jianjun Liu may publish in the future.

Co-authorship network of co-authors of Jianjun Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Jianjun Liu. A scholar is included among the top collaborators of Jianjun Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianjun Liu. Jianjun Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 7
5 2
6 2
7 14
8 33
9 20
10 4
11 46
12 172
13 43
14 13
15 29
16 21
17 27
18 151
19 22
20 26

About Jianjun Liu

Jianjun Liu is a scholar working on Cancer Research, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 32 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (6 papers), RNA modifications and cancer (6 papers) and Cancer, Lipids, and Metabolism (5 papers). The work is most often cited by research in Cancer Research (508 citations), Geriatrics and Gerontology (52 citations) and Molecular Biology (746 citations). Jianjun Liu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Gang Huang, Xiaoping Zhao, Li Zhao, Jiajin Li, Mengqin Shen, Shaoli Song, Ruixue Zhang, Hao Yang, Jun Wen and Hui Yan. Their work appears in journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and ACS Nano.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026